Skip to main content

Security report for alpenpharma.com

Alpen Pharma · Healthcare · Switzerland

Medium risk. 7 critical or high findings in Security headers, GDPR outside view and 2 other checks.

Security score

50/100

Risk levelMedium

0–100, higher is better. How it is calculated

Alpen Pharma is a healthcare-focused pharmaceutical company with an international presence, operating multiple country-specific websites to serve diverse markets. The company appears established since 2007, with a medium-sized business footprint primarily in the healthcare sector. Their website is built on WordPress, leveraging common plugins for forms and GDPR-compliant cookie consent, indicating a moderate level of digital maturity. The technical infrastructure includes modern JavaScript libraries and analytics tools, supporting a good user experience and mobile optimization. Security posture is adequate with HTTPS enforced and cookie consent implemented, though improvements such as enabling DNSSEC and adding security headers are recommended. Privacy compliance is strong with clear policies and opt-in mechanisms. However, contact information and security policies are not explicitly presented, which could impact user trust and compliance transparency. Overall, the website is professional and functional with room for enhanced security and business transparency.

Scanned

NIS2 and GDPR posture

GDPR outside view
80/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching alpenpharma.com

This scan found 26 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
52
Security headers
20
Email security
70
DNS health
60
Network security
20
GDPR outside view
80
Average
50

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company targets healthcare professionals and consumers across multiple countries, suggesting a broad distribution and sales model. The use of multiple country domains indicates a strategic approach to localization and market penetration. The business model centers on pharmaceutical manufacturing and distribution, with a focus on health and wellness. The absence of explicit contact details and security policies on the website may limit direct customer engagement and trust signals. The partnership ecosystem is not clearly defined in the public content. Growth indicators include a well-maintained website and GDPR compliance, but further business intelligence would require additional data sources.

Security posture

The website enforces HTTPS and uses a GDPR-compliant cookie consent mechanism, which are positive security indicators. However, the lack of DNSSEC and missing security headers such as Content-Security-Policy and X-Frame-Options represent areas for improvement. No explicit security or incident response policies are published, and no vulnerability disclosure or security.txt files are present, which limits transparency and readiness perception. The use of common WordPress plugins necessitates regular security audits to mitigate risks from vulnerable components. Overall, the security posture is moderate but could be strengthened with additional controls and published policies.

Recommendations

  1. Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
  2. Implement standard security headers (CSP, X-Frame-Options, X-Content-Type-Options) to protect against common web attacks.
  3. Publish a clear security policy and incident response contact information to improve transparency and trust.
  4. Establish a vulnerability disclosure program or security.txt file to facilitate responsible reporting.
  5. Add explicit company contact information on the website to improve business credibility and user trust.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Alpen Pharma
Description
Alpen Pharma is a healthcare company with a mission focused on health, offering pharmaceutical products and services across multiple countries.
Key services
Pharmaceutical product manufacturing, Distribution across various countries
Content quality
good
Branding
consistent

Technology

Stack
WordPress, jQuery, Swiper.js, Google Tag Manager, Google Analytics, Complianz GDPR Cookie Consent, Contact Form 7
Frameworks
WordPress
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
70/100
Good practices seen
  • HTTPS enabled
  • Cookie consent with opt-in mechanism
  • No exposed sensitive data found in HTML

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website uses WordPress CMS with multiple plugins for forms and cookie consent
  2. Cookie consent mechanism is opt-in and GDPR compliant
  3. No contact emails or phone numbers explicitly found in HTML content
  4. Multiple country-specific domains indicate international business operations
  5. No terms of service page detected
  6. No explicit security policy or incident response information found
  7. No vulnerability disclosure or security.txt found
  8. Logo URL found: https://alpenpharma.com/sites/default/files/logo.png
  9. No social media links explicitly found in provided HTML content
Technical notes

Notes

The website is built on WordPress 6.8.1 with a modern tech stack including jQuery, Swiper.js for sliders, and Google Tag Manager for analytics. The site uses multiple plugins such as Contact Form 7 and Complianz GDPR for cookie consent, indicating a mature CMS environment. Performance is moderate with autoplay sliders and asynchronous script loading. Mobile optimization is good, but accessibility features are basic. SEO is supported by proper meta tags and canonical links. Hosting provider is not explicitly identified but DNS uses swisscenter.com name servers, consistent with a Swiss presence. Technical debt appears low but security enhancements are recommended.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with alpenpharma.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review alpenpharma.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.